Associate Professor, Internal Medicine, UC, Davis School of Medicine
Hematology
Dr. Helen K. Chew, MD
|
|
Give Review
Helen Chew works in the field of Hematology. He went to University of Texas Medical School. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACP)". Helen K. Chew is a published MD. He published 39 publications, including: 'SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer.' Helen Chew accepts Medicare payments and is listed with Medicare.gov.
Publications
- SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer.
- Lymphoma and venous thromboembolism: influence on mortality.
- Satisfaction With Work-Life Balance and the Career and Retirement Plans of US Oncologists.
- Burnout and Career Satisfaction Among US Oncologists.
- The Potential Role of Radiation Therapy to the Primary Site of Disease in Stage IV Breast Cancer Presenting With Synchronous Metastasis.
- Richter's Syndrome With Aberrant CD2 and CD4 Expression.
- Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid Tumors.
- High-mannose glycans are elevated during breast Cancer progression.
- The incidence of venous thromboembolism and its effect on survival among patients with primary bladder Cancer.
- Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast Cancer treatment selection.
- Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast Cancer.
- Venous thromboembolism in patients with Acute leukemia: incidence, risk factors, and effect on survival.
- A phase II study of imatinib mesylate and capecitabine in metastatic breast Cancer: Southwest Oncology Group Study 0338.
- A serum glycomics approach to breast Cancer biomarkers.
- Incidence of venous thromboembolism and the impact on survival in breast Cancer patients.
- Venous thromboembolism in patients with colorectal Cancer: incidence and effect on survival.
- Incidence of venous thromboembolism and its effect on survival among patients with common Cancers.
- High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast Cancer by using a MUC-1 monoclonal antibody, m170, linked to in...
- Incidence of venous thromboembolism in the year before the diagnosis of Cancer in 528,693 adults.
- Medical management of breast Cancer: today and tomorrow.
- Detecting glycan Cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data.
- 25th Chemotherapy Foundation Symposium. Innovative Cancer Therapy for Tomorrow. 6-10 November 2007, New York, NY, USA.
- Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast Cancer: Southwest Oncology Group/Intergroup study 9623.
- Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment.
- BRCA1 cooperates with NUFIP and P-TEFb to activate transcription by RNA polymerase II.
- Emerging roles of BRCA1 in transcriptional regulation and DNA repair.
- Genetic evaluation of Cancer: the importance of family history.
- Adjuvant therapy for breast Cancer: who should get what?
- Biological functions of the BRCA1 protein.
- The incidence of venous thromboembolism among patients with primary lung Cancer.
- Epidemiology of venous thromboembolism in 9489 patients with Malignant glioma.
- Targeting patients for anticoagulant prophylaxis trials in patients with Cancer: who is at highest risk?
- Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast Cancer therapy.
- Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.
- Venous thromboembolism in ovarian Cancer.
- An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of Cancer clinical trial costs in California.
- Evidence of poorer survival in pregnancy-associated breast Cancer.
- Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast Cancer.
Schools
University of Texas Medical School At San Antonio
University Tex Health Science Center
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Benesys
- Blue Card PPO
- CaliforniaCare HMO
- Blue Cross Blue Shield of California PPO
- Pathway X Guided Access HMO
- Select Plus HMO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Delta Health System
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Humana
- Medicare MCR
- Molina
- MultiPlan PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
- Western Health Advantage
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACP)
Education
-
University of Texas Health Science Center -
University of Texas Medical School
Hospital
-
University of California, Davis Medical Center
Drug Facts
| NPI NUMBER | 1801870142 | |
| NPPES Provider LastName | CHEW | |
| NPPES Provider FirstName | HELEN | |
| NPPES Provider ZIPCode | 958172229 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 222.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801870142 |
| Last Name Of The Provider | CHEW |
| First Name Of The Provider | HELEN |
| View All |
Similar Doctors
|
|
Dr. Minh T. Huynh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James S. Chang, MD |
|
|
Dr. Denis M. Dwyre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol M. Richman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sidney A. Scudder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Tanaka Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald M. Wisdom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen E. Wang, MD |
|
|
Dr. Kendra Hutchinson, MD
This Doctor is OpenDoctor Recommended.
|